Skip to main content
OpenTrials
Completed

NCT Number: NCT01050374

Safety and Efficacy of Drug Combinations Against Schistosomiasis

This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of MBD in combination with PZQ in the treatment of SCH and STH in children aged 1-15 years of age.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vector Control Division

Kampala, Uganda

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those with an age of 1-15 years of age
  • Are infected with schistosomiasis and soil-transmitted helminthiasis
  • Whose parent consent and who are willing to participate

Exclusion criteria

  • Those with acute and chronic diseases other than schistosomiasis and soil-transmitted helminthiasis
  • Those with a history of any serious adverse drug reactions

Treatment and study plan

albendazole + praziquantel

Drug

albendazole (400 mg one dose) + praziquantel (40 mg/kg body weight)

mebendazole + praziquantel

Drug

mebendazole (500 mg one dose) + praziquantel (40 mg/kg body weight)

Primary outcomes

  1. Efficacy of treatment

    Time frame: 6 weeks

Secondary outcomes

  1. Record of adverse reactions

    Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

DBL -Institute for Health Research and Development

Other

Registry information

Official study title

Gaps in Helminth Control: Safety and Efficacy of Drug Combinations. Praziquantel Study

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Jan 15, 2010
Registry last updated
Jan 15, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.